S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom

ResMed (RMD) Insider Trading & Ownership

$173.86
-11.00 (-5.95%)
(As of 04/17/2024 ET)

ResMed (NYSE:RMD) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
1.21%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
7
Amount Of
Insider Selling
(Last 12 Months)
$15.03 M
Get RMD Insider Trade Alerts

Want to know when executives and insiders are buying or selling ResMed stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

RMD Insider Buying and Selling by Quarter

ResMed Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/4/2024Michael J RiderGeneral CounselSell81$180.00$14,580.00  
3/1/2024Michael J RiderGeneral CounselSell200$173.25$34,650.00  
2/22/2024Peter C FarrellDirectorSell10,935$182.66$1,997,387.10  
11/27/2023Brett SandercockCFOSell3,000$152.62$457,860.00  
11/15/2023Michael J FarrellCEOSell5,678$152.04$863,283.12  
11/1/2023Michael J RiderGeneral CounselSell25$143.42$3,585.50  
10/17/2023Tommy TubervilleU.S. Congress Member (R-AL)Buy$141.84$1,001 - $15,000
10/16/2023Michael J FarrellCEOSell5,675$140.70$798,472.50  
10/2/2023Michael J RiderGeneral CounselSell25$145.92$3,648.00  
9/15/2023Michael J FarrellCEOSell5,675$146.35$830,536.25  
8/29/2023Thomas R. CarperU.S. Congress Member (D-DE)Buy$163.93$1,001 - $15,000
8/15/2023Michael J FarrellCEOSell5,675$183.20$1,039,660.00  
8/15/2023Robert Andrew DouglasCOOSell1,500$181.01$271,515.00  
8/1/2023Michael J RiderGeneral CounselSell25$224.12$5,603.00  
7/17/2023Michael J FarrellCEOSell5,675$221.27$1,255,707.25  
7/17/2023Robert Andrew DouglasCOOSell1,500$222.22$333,330.00  
7/13/2023Kaushik GhoshalInsiderSell500$220.00$110,000.00  
7/3/2023Michael J RiderGeneral CounselSell25$217.21$5,430.25  
6/15/2023Michael J FarrellCEOSell5,675$217.39$1,233,688.25  
6/15/2023Robert Andrew DouglasCOOSell1,500$216.27$324,405.00  
6/5/2023David PendarvisInsiderSell1,500$219.79$329,685.00  
6/2/2023Kaushik GhoshalInsiderSell500$220.00$110,000.00  
5/15/2023Michael J FarrellCEOSell5,675$232.10$1,317,167.50  
5/15/2023Robert Andrew DouglasCOOSell1,500$232.85$349,275.00  
5/9/2023Brett SandercockCFOSell3,426$232.05$795,003.30  
5/3/2023David PendarvisInsiderSell1,500$237.64$356,460.00  
5/1/2023Kaushik GhoshalInsiderSell500$239.30$119,650.00  
4/24/2023Kaushik GhoshalInsiderSell2,000$230.00$460,000.00  
4/17/2023Michael J FarrellCEOSell5,675$224.23$1,272,505.25  
4/17/2023Robert Andrew DouglasCOOSell1,500$224.65$336,975.00  
(Data available from 1/1/2013 forward)

RMD Insider Trading Activity - Frequently Asked Questions

What percentage of ResMed stock is owned by insiders?

1.21% of ResMed stock is owned by insiders. Learn more on RMD's insider holdings.

Which ResMed insiders have been selling company stock?

The following insiders have sold RMD shares in the last 24 months: Brett Sandercock ($5,325,093.30), David Pendarvis ($4,340,365.95), Justin Leong ($866,821.50), Karen Drexler ($134,588.52), Kaushik Ghoshal ($799,650.00), Lucile Blaise ($38,055.42), Michael J Farrell ($23,231,774.27), Michael J Rider ($67,496.75), Peter C Farrell ($4,006,306.10), and Robert Andrew Douglas ($11,990,775.94).

How much insider selling is happening at ResMed?

Insiders have sold a total of 239,134 ResMed shares in the last 24 months for a total of $50,800,927.75 sold.

Which members of congress are trading ResMed?

Tommy Tuberville (R-AL) and Thomas R. Carper (D-DE) have bought shares of ResMed in the last year totaling $16,000.


More Insider Trading Tools from MarketBeat

This page (NYSE:RMD) was last updated on 4/17/2024 by MarketBeat.com Staff

From Our Partners